Unsecured MSME stress may persist
Small-ticket unsecured MSME loans (1.3% of portfolio) show elevated stress with GNPA at 5.4%, though management is cautious and has tightened underwriting.
Aditya Birla Capital · risk themes across the available quarters.
Bear-case history
Small-ticket unsecured MSME loans (1.3% of portfolio) show elevated stress with GNPA at 5.4%, though management is cautious and has tightened underwriting.
Net interest margin including fees fell to 5.97% as higher-yielding unsecured segments were curtailed; recovery depends on growth in personal/consumer loans.
Analyst raised concern about balance transfer out in prime housing loans amid repo rate cuts; management acknowledged elevated foreclosures but expects balanced growth.
Group traditional fund premium declined 51% YoY strategically due to falling interest rates, impacting total premium and opex ratio.
Analyst raised concerns about potential regulatory changes on life insurance fee/commission structures and agent payouts following media reports. Management acknowledged it as an industry-level risk but provided no specific mitigation plan.
As personal & consumer and unsecured business mix increases from current ~25% toward 30%, yields have compressed ~30bps over four quarters. Management indicated margin expansion would only materialize when unsecured mix reaches 27-28%, which may take several more quarters.
While partnership/bank assurance grew 25% YoY, proprietary channel growth was lower at 7%. Management attributed this to industry-wide agency channel softness but did not provide specific turnaround timeline for proprietary growth acceleration.
Despite improvement from 107% last year, the combined ratio remains above 100%, meaning the health insurance business is still technically underwriting at a loss before investment income. Management targets achieving 100% combined ratio during FY27.
Despite favorable mix shift towards unsecured lending, management indicated it will take a couple of quarters for yields to improve at the portfolio level, potentially delaying NIM expansion.
Analysts raised concerns about potential ECL model changes after a peer increased provisions; management downplayed the need, but regulatory nudges could alter provisioning requirements.
Life insurance margins face headwinds from GST changes; only 40% of the impact has been mitigated via commercial arrangements, with the balance to be managed through product strategy.
The ₹2,750 crore capital infusion from Advent International is subject to CCI approval, expected by end of March 2026, but any delay could slow growth plans.